Clinical Trials on Gallbladder Dyskinesia in France

Total 371 results

Ramsay Générale de Santé
European Clinical Trial Experts Network

Recruiting

Influence of an Anterior Latarjet-type Abutment Operation on Scapular Dyskinesia and the Muscular Stabilization Mechanisms of the Scapula (DyScapLat) (DyScapLat)

Latarjet | Scapular Dyskinesis

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Assessment of ADCY5-related Movement Disorders With Motion SENSors (SENSeo-ADCY5)

ADCY5-related Dyskinesia

France
Centre Hospitalier Universitaire, Amiens

Completed

Xenazine in Late Dyskinetic Syndrome With Neuroleptics (Xeladys)

Tardive Dyskinesia

France
University Hospital, Montpellier

Terminated

Validation of the Implantation of a New Electrode for the Treatment of Dystonia (MONOCONTACT)

Tardive Dystonia | Generalized Dystonia | Segmental Dystonia

France
Fondation Ophtalmologique Adolphe de Rothschild

Terminated

Effect of the Visual Information Change in Functional Dystonia (PRISMADYS)

Central Nervous System Diseases | Nervous System Diseases | Neurologic Manifestations | Movement Disorders | Dyskinesias | Dystonia | Dystonic Disorders | Torticollis

France
Auspex Pharmaceuticals, Inc.

Completed

Aim to Reduce Movements in Tardive Dyskinesia (ARM-TD)

Tardive Dyskinesia

United States, Poland, Czechia, Slovakia
Auspex Pharmaceuticals, Inc.

Completed

Reducing Involuntary Movements in Participants With Tardive Dyskinesia (RIM-TD)

Tardive Dyskinesia

United States, Czechia, Germany, Hungary, Poland, Slovakia
Auspex Pharmaceuticals, Inc.

Completed

Addressing Involuntary Movements in Tardive Dyskinesia (AIM-TD)

Tardive Dyskinesia

United States, Czechia, Germany, Hungary, Poland, Slovakia
University Hospital, Montpellier

Recruiting

Validation of a Quality of Life Assessment Tool in Adult Generalized Dystonodyskinetic Syndromes Treated by Continuous Electrical Neuromodulation (DBS-QoLs)

Dystono-dyskinetic Syndromes

France
IHU Strasbourg

Completed

Fluorescence Versus Intraoperative Cholangiography in the Visualization of Biliary Tree Anatomy (FLARIOC)

Cholelithiasis | Gallbladder Polyps

France
Novartis Pharmaceuticals

Completed

Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

Dyskinesias | Drug-induced

United States, France, Germany, Italy
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Recruiting

Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer

Stage II Gallbladder Cancer AJCC v8 | Stage IIA Gallbladder Cancer AJCC v8 | Stage IIB Gallbladder Cancer AJCC v8 | Stage III Gallbladder Cancer AJCC v8 | Stage IIIA Gallbladder Cancer AJCC v8 | Stage IIIB Gallbladder Cancer AJCC v8

United States
Assistance Publique - Hôpitaux de Paris

Completed

Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease (BUSPARK)

Parkinson

France
Neurocrine Biosciences

Completed

NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)

Tardive Dyskinesia

United States, Puerto Rico
Centre Hospitalier Intercommunal Creteil

Completed

Bacteriological Link Between Upper and Lower Airways in Cystic Fibrosis and Primary Ciliary Dyskinesia (BAVASI)

Cystic Fibrosis | Primary Ciliary Dyskinesia

France
Centre Hospitalier Universitaire, Amiens

Recruiting

Subthalamic Nucleus Stimulation With Directional Leads on Patients With Parkinson Disease at Fluctuations and Dyskinesia Stage (NSTBOS)

Parkinson Disease | Subthalamic Nucleus Stimulation | Directional Electrodes

France
Aerocrine AB

Completed

NIOX VERO Nasal Application in Primary Ciliary Dyskinesia

PCD

France, United States, Denmark, Germany
Assistance Publique - Hôpitaux de Paris

Completed

Diagnosis of Primary Ciliary Dyskinesia (DCP)

Primary Ciliary Dyskinesia | Kartagener Syndrome

France
Institut de cancérologie Strasbourg Europe
University of Oslo; Oslo University Hospital; University of Bristol; Heidelberg... and other collaborators

Recruiting

EULAT Eradicate GBC (EULAT)

Gallbladder Cancer | Gallstone Disease

Chile, France, Argentina, Bolivia, Peru
Centre Hospitalier Universitaire de Besancon

Not yet recruiting

Diagnostic Performance of Dual Energy CT for the Detection of Gallbladder Gallstones (DUAL-GB)

Gallstone

France
Assistance Publique Hopitaux De Marseille

Unknown

Reduction of Operating Time by a Smoke Electroprecipitation Device for Acute Cholecystitis (Ultravision)

Cholecystitis

France
Institut National de la Santé Et de la Recherche...

Recruiting

DCP (RaDiCo Cohort) (RaDiCo-DCP) (DCP)

Primary Ciliary Dyskinesia

France
National Cancer Institute (NCI)

Recruiting

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Cholangiocarcinoma | Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Gallbladder Carcinoma | Stage III Gallbladder Cancer AJCC v8 | Stage III Hilar Cholangiocarcinoma AJCC v8 | Stage IV Gallbladder Cancer AJCC v8 | Stage IV Hilar Cholangiocarcinoma AJCC v8 | Stage IV Intrahepatic Cholangiocarcinoma...

United States
Contera Pharma
Bukwang Pharmaceutical

Active, not recruiting

A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia (ASTORIA)

Dyskinesias

France, Germany, Italy, Korea, Republic of, Spain
Novartis Pharmaceuticals

Completed

Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Parkinson Disease | Parkinsonian Disorders | Movement Disorders | Dyskinesias | Anti-Dyskinesia Agents

Spain, United States, Austria, Switzerland, France, Germany, Italy, Canada, Hungary, Slovakia
Novartis Pharmaceuticals

Completed

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Parkinson Disease | Parkinsonian Disorders | Movement Disorders | Dyskinesias | Anti-Dyskinesia Agents

Spain, United States, Austria, Switzerland, France, Germany, Italy, Hungary, Canada, Slovakia
Neurocrine Biosciences

Recruiting

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder | Tardive Dyskinesia | Major Depressive Disorder

United States
Newron Pharmaceuticals SPA

Completed

Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects (Safinamide-LID)

Parkinson's Disease

Austria, Canada, France, Germany, South Africa
Adamas Pharmaceuticals, Inc.

Terminated

Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID (ALLAY-LID-II)

Parkinson's Disease | Levodopa Induced Dyskinesia (LID)

France, Germany, Canada, United States, Spain
Physio-Assist
University Hospital, Marseille; CEISO

Terminated

Evaluation of the Safety of the Medical Device Simeox® (SIMETOL)

Cystic Fibrosis | Chronic Bronchitis | Chronic Obstructive Airway Disease | Broncho-degenerative Disease | Idiopathic Bronchiectasis | Ciliary Dyskinesia

France
National Cancer Institute (NCI)

Terminated

Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Cholangiocarcinoma... and other conditions

United States
Adamas Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia (EASE LID 3)

Parkinson's Disease (PD) | Dyskinesia | Levodopa-Induced Dyskinesia (LID)

France, Spain, United States, Germany, Austria
Adamas Pharmaceuticals, Inc.

Terminated

Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID. (ALLAY-LID-I)

Parkinson's Disease | Levodopa Induced Dyskinesias (LID)

France, Spain, Germany, Canada, United States
University Hospital, Toulouse

Completed

Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease (PREMANDYSK)

Parkinson Disease

France
National Cancer Institute (NCI)

Completed

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Hilar Cholangiocarcinoma | Recurrent Gallbladder Carcinoma | Unresectable Extrahepatic Bile Duct Carcinoma | Unresectable Gallbladder Carcinoma | Gallbladder Adenocarcinoma | Recurrent Extrahepatic Bile Duct Carcinoma | Extrahepatic Bile Duct Adenocarcinoma | Gallbladder Adenocarcinoma With Squamous... and other conditions

United States
Rush University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Validation of Dyskinesia Rating Scales

Parkinson's Disease

United States, Austria, Canada, France
UNICANCER

Completed

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer

France
Centre Hospitalier Intercommunal Creteil

Recruiting

Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy (CILTUBE)

Ectopic Pregnancy | Hysterectomy | Primary Ciliary Dyskinesia | Salpingectomy

France
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)

Cholangiocarcinoma | Biliary Tract Cancer | Gallbladder Cancer

Korea, Republic of, United States, Taiwan, Italy, France, China, Japan, Spain, United Kingdom
University Hospital, Montpellier

Completed

Laparoscopic Treatment of Common Bile Duct Stones : What Are the Limits and When Should we Call the Endoscopist ?

Laparoscopic | Common Bile Duct Stone With Chronic Cholecystitis

France
Adamas Pharmaceuticals, Inc.

Completed

Open-Label Safety Study of ADS-5102 in PD Patients With LID

Parkinson's Disease (PD) | Dyskinesia | Levodopa Induced Dyskinesia (LID)

France, Spain, United States, Canada, Germany, Austria
Federation Francophone de Cancerologie Digestive

Completed

Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery

Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer

France
Centre Hospitalier Universitaire, Amiens

Recruiting

Interest of Intravenous Cholangiography With Indocyanine Green in the Context of Laparoscopic Cholecystectomy for Grade 1 and 2 Acute Gallstone Cholecystitis (VIFCAL)

Cholecystitis, Acute | Lithiasis | Cholangiopathy

France
CMC Ambroise Paré

Completed

Interest of Catalepsy in the Hypnotic Trance (CATALHYPNOANI)

Hypnosis

France
Eisai Limited

Completed

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias

Parkinson's Disease

Czech Republic, France, Germany, Italy, Serbia, Spain
Novartis Pharmaceuticals

Completed

Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Parkinson Disease | Dyskinesia, Drug-Induced | Levodopa

Italy, United States, Australia, France, Germany, Canada
Addex Pharma S.A.

Completed

ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

Parkinson's Disease

United States, Austria, France, Germany
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

Stage III Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 | Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 | Stage III Gallbladder Cancer AJCC v8 | Stage IIIA Gallbladder Cancer AJCC v8 | Stage IIIB Gallbladder Cancer AJCC v8 | Unresectable Extrahepatic... and other conditions

United States
Assistance Publique Hopitaux De Marseille

Unknown

Evaluation of the Predictors of Clinical and Radiological Response to Gamma-Knife Radiosurgery in the Treatment of Intermediate Ventral Nucleus of the Thalamus (VIM) Thalamotomy Tremor. (GARP)

Severe Disabling Tremor

France
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Terminated

Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC

Cholangiocarcinoma | Biliary Tract Cancer | Gallbladder Cancer

Korea, Republic of, United States, Taiwan, China, Argentina, Australia, Brazil, Chile, France, Germany, Italy, Japan, Poland, Spain, United Kingdom

Clinical Trials on Gallbladder Dyskinesia in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations